Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tozorakimab (MEDI-3506), a human immunoglobulin G1 monoclonal antibody, targets interleukin-33 and is utilized in researching chronic obstructive pulmonary disease (COPD) [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Tozorakimab (MEDI-3506), a human immunoglobulin G1 monoclonal antibody, targets interleukin-33 and is utilized in researching chronic obstructive pulmonary disease (COPD) [1]. |
Molecular Weight | 15.03 |
CAS No. | 2376858-66-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tozorakimab 2376858-66-9 inhibitor inhibit